• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非阻塞性冠状动脉疾病患者发生心绞痛的危险因素:一项回顾性分析

Risk Factors Predisposing to Angina in Patients with Non-Obstructive Coronary Arteries: A Retrospective Analysis.

作者信息

Wiśniewski Oskar Wojciech, Dydowicz Franciszek, Salamaga Szymon, Skulik Przemysław, Migaj Jacek, Kałużna-Oleksy Marta

机构信息

Faculty of Medicine, Poznan University of Medical Sciences, 10 Fredry Street, 61-701 Poznan, Poland.

1st Department of Cardiology, Poznan University of Medical Sciences, 1/2 Dluga Street, 61-848 Poznan, Poland.

出版信息

J Pers Med. 2022 Jun 27;12(7):1049. doi: 10.3390/jpm12071049.

DOI:10.3390/jpm12071049
PMID:35887545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318432/
Abstract

No hemodynamically significant atherosclerotic plaques are observed in up to 30% of patients reporting angina and undergoing coronary angiography. To investigate risk factors associated with non-obstructive coronary artery disease (NOCAD), we analyzed the medical records of, consecutively, 136 NOCAD subjects and 128 patients with significant stenosis in at least one coronary artery (the OCAD group). The blood concentrations of the TC (4.40 [3.78−5.63] mmol/L vs. 4.12 [3.42−5.01] mmol/L; p = 0.026), LDL-C (2.32 [1.80−3.50] mmol/L vs. 2.10 [1.50−2.70] mmol/L; p = 0.003), non-HDL-C (2.89 [2.29−4.19] mmol/L vs. 2.66 [2.06−3.39] mmol/L; p = 0.045), as well as the LDL-C/HDL-C ratio (1.75 [1.22−2.60] vs. 1.50 [1.10−1.95]; p = 0.018) were significantly increased in the NOCAD patients compared to the OCAD group due to the lower prevalence and intensity of the statin therapy in the NOCAD individuals (p < 0.001). Moreover, the abovementioned lipid parameters appeared to be valuable predictors of NOCAD, with the LDL-C (OR = 1.44; 95%CI = 1.14−1.82) and LDL-C/HDL-C (OR = 1.51; 95%CI = 1.13−2.02) showing the highest odds ratios. Furthermore, multivariable logistic regression models determined female sex as the independent risk factor for NOCAD (OR = 2.37; 95%CI = 1.33−4.20). Simultaneously, arterial hypertension substantially lowered the probability of NOCAD (OR = 0.21; 95%CI = 0.10−0.43). To conclude, female sex, the absence of arterial hypertension, as well as increased TC, LDL-C, non-HDL, and LDL-C/HDL-C ratio are risk factors for NOCAD in patients reporting angina, potentially as a result of poor hypercholesterolemia management.

摘要

在报告有胸痛症状并接受冠状动脉造影的患者中,高达30%的患者未观察到具有血流动力学意义的动脉粥样硬化斑块。为了研究与非阻塞性冠状动脉疾病(NOCAD)相关的危险因素,我们连续分析了136例NOCAD患者和128例至少有一支冠状动脉存在明显狭窄的患者(阻塞性冠状动脉疾病组,OCAD组)的病历。由于NOCAD患者他汀类药物治疗的患病率和强度较低(p<0.001),与OCAD组相比,NOCAD患者的总胆固醇(TC)血浓度(4.40[3.78−5.63]mmol/L对4.12[3.42−5.01]mmol/L;p = 0.026)、低密度脂蛋白胆固醇(LDL-C)(2.32[1.80−3.50]mmol/L对2.10[1.50−2.70]mmol/L;p = 0.003)、非高密度脂蛋白胆固醇(non-HDL-C)(2.89[2.29−4.19]mmol/L对2.66[2.06−3.39]mmol/L;p = 0.045)以及LDL-C/HDL-C比值(1.75[1.22−2.60]对1.50[1.10−1.95];p = 0.018)显著升高。此外,上述血脂参数似乎是NOCAD的有价值预测指标,其中LDL-C(OR = 1.44;95%CI = 1.14−1.82)和LDL-C/HDL-C(OR = 1.51;95%CI = 1.13−2.02)的比值比最高。此外,多变量逻辑回归模型确定女性性别是NOCAD的独立危险因素(OR = 2.37;95%CI = 1.33−4.20)。同时,动脉高血压显著降低了患NOCAD的概率(OR = 0.21;95%CI = 0.10−0.43)。总之,女性性别、无动脉高血压以及TC、LDL-C、非HDL和LDL-C/HDL-C比值升高是报告有胸痛症状患者患NOCAD的危险因素,这可能是由于高胆固醇血症管理不善所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981e/9318432/11fd38008b1d/jpm-12-01049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981e/9318432/11fd38008b1d/jpm-12-01049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981e/9318432/11fd38008b1d/jpm-12-01049-g001.jpg

相似文献

1
Risk Factors Predisposing to Angina in Patients with Non-Obstructive Coronary Arteries: A Retrospective Analysis.非阻塞性冠状动脉疾病患者发生心绞痛的危险因素:一项回顾性分析
J Pers Med. 2022 Jun 27;12(7):1049. doi: 10.3390/jpm12071049.
2
Impaired retinal microcirculation in patients with non-obstructive coronary artery disease.非阻塞性冠状动脉疾病患者的视网膜微循环受损。
Microvasc Res. 2023 Jul;148:104533. doi: 10.1016/j.mvr.2023.104533. Epub 2023 Mar 31.
3
Impaired peripheral microvascular reactivity in patients with nonobstructive coronary artery disease.非阻塞性冠状动脉疾病患者的外周微血管反应受损。
Microcirculation. 2023 May;30(4):e12807. doi: 10.1111/micc.12807. Epub 2023 Apr 20.
4
Impact of clinical presentation and presence of coronary sclerosis on long-term outcome of patients with non-obstructive coronary artery disease.临床表现及冠状动脉硬化对非阻塞性冠状动脉疾病患者长期预后的影响。
BMC Cardiovasc Disord. 2018 Aug 22;18(1):173. doi: 10.1186/s12872-018-0908-z.
5
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study.非阻塞性冠状动脉疾病患者的风险因素控制和基于指南的医学治疗是否最佳?一项退伍军人事务研究。
Am J Med Sci. 2013 May;345(5):339-42. doi: 10.1097/MAJ.0b013e31825c6951.
6
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防:空军/德州冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
7
Incidence and characteristics of patients presenting with acute myocardial infarction and non-obstructive coronary artery disease.急性心肌梗死合并非阻塞性冠状动脉疾病患者的发病率及特征
Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S23-7. doi: 10.1002/ccd.26043. Epub 2015 Jun 23.
8
Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?高密度脂蛋白胆固醇升高对冠心病总是有益吗?
Clin Cardiol. 2007 Nov;30(11):576-80. doi: 10.1002/clc.20137.
9
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.刚果动脉高血压患者血清脂质和脂蛋白的相关因素
Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.
10
Low utilisation of cardiovascular risk reducing therapy in patients with acute coronary syndromes and non-obstructive coronary artery disease.急性冠状动脉综合征和非阻塞性冠状动脉疾病患者心血管风险降低治疗的利用率低。
Int J Cardiol. 2008 Oct 13;129(3):394-8. doi: 10.1016/j.ijcard.2007.12.023. Epub 2008 Mar 4.

引用本文的文献

1
Relationship Between Carotid Intraplaque Neovascularization and Immune-Inflammatory Biomarkers with Coronary Stenosis.颈动脉斑块内新生血管形成及免疫炎症生物标志物与冠状动脉狭窄的关系
Rev Cardiovasc Med. 2025 May 23;26(5):28171. doi: 10.31083/RCM28171. eCollection 2025 May.
2
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and angina pectoris in US adults: a cross-sectional retrospective study based on NHANES 2009-2018.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与美国成年人心绞痛的关系:基于 NHANES 2009-2018 的横断面回顾性研究。
Lipids Health Dis. 2024 Oct 26;23(1):347. doi: 10.1186/s12944-024-02343-2.
3

本文引用的文献

1
Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.非阻塞性冠状动脉疾病患者中冠状动脉微血管疾病和冠状动脉痉挛的患病率:系统评价和荟萃分析。
J Am Heart Assoc. 2022 Apr 5;11(7):e023207. doi: 10.1161/JAHA.121.023207. Epub 2022 Mar 18.
2
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.2型糖尿病患者的微血管功能障碍:绝对冠状动脉血流和微血管阻力储备的有创评估
Front Cardiovasc Med. 2021 Oct 19;8:765071. doi: 10.3389/fcvm.2021.765071. eCollection 2021.
3
Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B among Prinzmetal Angina Patients and Healthy Persons.
稳定性心绞痛患者和健康人群中遵行地中海饮食与血清一氧化氮、前列环素和血栓素 B 水平的关系。
Nutrients. 2023 Feb 1;15(3):738. doi: 10.3390/nu15030738.
Revisiting the use of the provocative acetylcholine test in patients with chest pain and nonobstructive coronary arteries: A five-year follow-up of the AChPOL registry, with special focus on patients with MINOCA.
重新探讨在胸痛且非阻塞性冠状动脉疾病患者中应用激发乙酰胆碱试验:AChPOL 注册研究的 5 年随访结果,特别关注 MINOCA 患者。
Transl Res. 2021 May;231:64-75. doi: 10.1016/j.trsl.2020.11.009. Epub 2020 Nov 21.
4
Gender Differences in Non-Obstructive Coronary Artery Disease.非阻塞性冠状动脉疾病中的性别差异。
Curr Pharm Des. 2021;27(29):3198-3209. doi: 10.2174/1381612826666201012163845.
5
Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease.可溶性尿激酶型纤溶酶原激活物受体和高敏肌钙蛋白水平预测非阻塞性冠状动脉疾病的结局。
J Am Heart Assoc. 2020 Apr 21;9(8):e015515. doi: 10.1161/JAHA.119.015515. Epub 2020 Apr 17.
6
Non-obstructive coronary artery disease can no longer be ignored.非阻塞性冠状动脉疾病再也不容忽视了。
Eur Heart J Cardiovasc Imaging. 2020 May 1;21(5):489-490. doi: 10.1093/ehjci/jeaa022.
7
Sex differences in non-obstructive coronary artery disease.非阻塞性冠状动脉疾病中的性别差异。
Cardiovasc Res. 2020 Mar 1;116(4):829-840. doi: 10.1093/cvr/cvaa001.
8
Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease).稳定型缺血性心脏病(非阻塞性冠状动脉疾病和阻塞性冠状动脉疾病)中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):771-786. doi: 10.1093/cvr/cvaa005.
9
Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.三酰甘油与高密度脂蛋白胆固醇比值对经皮冠状动脉介入治疗后冠心病患者长期死亡率的预测作用:一项回顾性队列研究。
Lipids Health Dis. 2019 Dec 4;18(1):210. doi: 10.1186/s12944-019-1152-y.
10
Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention.单核细胞/高密度脂蛋白胆固醇比值作为经皮冠状动脉介入治疗的冠心病患者的长期预后标志物。
Lipids Health Dis. 2019 Oct 22;18(1):180. doi: 10.1186/s12944-019-1116-2.